These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4790259)

  • 1. [Studies on evaluation of iron depots in terminal kidney failure].
    Kramer P; Hauswaldt C; Lankisch PG; Schrader C; Otten E; Köthe E; Scheler F
    Verh Dtsch Ges Inn Med; 1973; 79():455-8. PubMed ID: 4790259
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 3. Egg on the table.
    Kazama JJ; Kaneko Y
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):14-5. PubMed ID: 19129315
    [No Abstract]   [Full Text] [Related]  

  • 4. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
    Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyposideremia in chronic renal failure].
    Olmer M; Hamon J; Sainty D; Salvadori JM; Bouvenot G; Mongin M; Olmer J
    Presse Med (1893); 1971 Jan; 79(6):223-6. PubMed ID: 5546786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iron metabolism in terminal kidney insufficiency].
    Bechstein PB; Koch KM
    Med Klin Prax; 1982 Mar; 77(7):38-41, 66. PubMed ID: 7078511
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships between the copper and iron systems in hemodialysis patients and variables affecting these systems.
    Kirschbaum B
    Biol Trace Elem Res; 2000 Oct; 77(1):13-24. PubMed ID: 11097467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron absorption and retention in chronic renal failure.
    Hawkins JB; Sammons HG; Smits BJ; Robinson BH
    Gut; 1969 Dec; 10(12):1054. PubMed ID: 5366267
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron metabolism with particular reference to chronic renal failure and haemodialysis.
    Boddy K; King PC; Will G; Linton A; Lawson DH
    Br J Radiol; 1970 Apr; 43(508):286-7. PubMed ID: 5429445
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia.
    Milman N
    Clin Nephrol; 1982 Feb; 17(2):77-81. PubMed ID: 6802544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron metabolism in patients in kidney failure dialysis treatment].
    Zadrazil J; Bachleda P; Papajík T; Scudla V; Zahálková J; Budíková M; Novotný D
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():95-7. PubMed ID: 7976690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ferrokinetic studies in patients with chronic renal insufficiency].
    Marañon Cabello A
    Sangre (Barc); 1972; 17(2):223-7. PubMed ID: 5035461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Iron in the dialyzed chronic renal insufficiency patient: an aspect that is too frequently neglected].
    Canaud B; Kessler M; Chanliau J
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S289. PubMed ID: 17373272
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum ferritin in subjects with chronic renal insufficiency undergoing hemodialytic treatment].
    Allegra V; Mengozzi G; Spulzaro P; Tenti M; Amendolagine F; Vasile A
    Minerva Nefrol; 1983; 30(1):33-42. PubMed ID: 6843884
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron supplementation in children on hemodialysis.
    Leijn E; Monnens LA; Cornelissen EA
    J Nephrol; 2004; 17(3):423-6. PubMed ID: 15365964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of iron absorption in children with chronic renal insufficiency].
    Roszkowska-Blaim M; Korniszewska J; Makarewicz W
    Wiad Lek; 1994 Sep; 47(17-18):659-65. PubMed ID: 7571614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.